StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$1.89−0.06 (-3.08%)

Close on Nov 18, 2026Market cap $2.85MP/E –Yield –

Apimeds Pharmaceuticals US market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Apimeds Pharmaceuticals US's market cap was $3.56M on Nov 11, 2026, against $36.47M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.56M-82.7%
2025Dec 31, 2025$20.62M–

More Apimeds Pharmaceuticals US figures

See a number that looks wrong?